Emer P. Reeves

7.4k total citations · 1 hit paper
107 papers, 5.6k citations indexed

About

Emer P. Reeves is a scholar working on Pulmonary and Respiratory Medicine, Immunology and Cancer Research. According to data from OpenAlex, Emer P. Reeves has authored 107 papers receiving a total of 5.6k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Pulmonary and Respiratory Medicine, 35 papers in Immunology and 25 papers in Cancer Research. Recurrent topics in Emer P. Reeves's work include Cystic Fibrosis Research Advances (27 papers), Neonatal Respiratory Health Research (27 papers) and Protease and Inhibitor Mechanisms (24 papers). Emer P. Reeves is often cited by papers focused on Cystic Fibrosis Research Advances (27 papers), Neonatal Respiratory Health Research (27 papers) and Protease and Inhibitor Mechanisms (24 papers). Emer P. Reeves collaborates with scholars based in Ireland, United States and United Kingdom. Emer P. Reeves's co-authors include Noel G. McElvaney, Kevin Kavanagh, Anthony W. Segal, David A. Bergin, Frans B. Wientjes, Carlo Messina, Jürgen Roes, Hui Lu, Eric O. Potma and Giorgio Gabella and has published in prestigious journals such as Nature, New England Journal of Medicine and The Lancet.

In The Last Decade

Emer P. Reeves

105 papers receiving 5.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Killing activity of neutrophils is mediated through activation of proteases by K+ flux

2002 877 citations Emer P. Reeves et al. profile →

Peers

Countries citing papers authored by Emer P. Reeves

Since Specialization

Citations

This map shows the geographic impact of Emer P. Reeves's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emer P. Reeves with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emer P. Reeves more than expected).

Fields of papers citing papers by Emer P. Reeves

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emer P. Reeves. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emer P. Reeves. The network helps show where Emer P. Reeves may publish in the future.

Co-authorship network of co-authors of Emer P. Reeves

This figure shows the co-authorship network connecting the top 25 collaborators of Emer P. Reeves. A scholar is included among the top collaborators of Emer P. Reeves based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emer P. Reeves. Emer P. Reeves is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Fostering Equity and Advocacy in a High School Biology Classroom: A Case Study Approach to Genetics and Social Justice 2025 ·The Science Teacher ·(unknown), Sun Young Jeong, Emer P. Reeves, (unknown)	0
2	The vacuolar anti-Pseudomonal activity of neutrophil primary granule peptidyl-arginine deiminase enzymes 2024 ·Frontiers in Immunology ·(unknown), (unknown), (unknown), Kerstin Pohl, Kevin Kavanagh, Fidelma Fitzpatrick, Debananda Gogoi, Emer P. Reeves	1
3	Does Adenosine Triphosphate via Purinergic Receptor Signalling Fuel Pulmonary Fibrosis? 2024 ·Journal of Innate Immunity ·(unknown), Debananda Gogoi, (unknown), Cormac McCarthy, Michael P. Keane, Emer P. Reeves, Emmet E. McGrath	1
4	Trikafta Rescues CFTR and Lowers Monocyte P2X7R-induced Inflammasome Activation in Cystic Fibrosis 2022 ·American Journal of Respiratory and Critical Care Medicine ·Claudie Gabillard-Lefort, Michelle Casey, (unknown), Fiona Boland, (unknown), (unknown), (unknown), Cedric Gunaratnam, Noel G. McElvaney, Emer P. Reeves	33
5	Anti-cytokines as a Strategy in Alpha-1 Antitrypsin Deficiency 2020 ·Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation ·Oisín F. McElvaney, Mark P. Murphy, Emer P. Reeves, Noel G. McElvaney	14
6	Circulating Truncated Alpha-1 Antitrypsin Glycoprotein in Patient Plasma Retains Anti-Inflammatory Capacity 2019 ·The Journal of Immunology ·Emer P. Reeves, Danielle M. Dunlea, (unknown), (unknown), Tomás P. Carroll, Radka Saldova, (unknown), Mark R. Wormald, Oliver J. McElvaney, (unknown), Michael Henry, Paula Meleady, Joanne Keenan, Derek C. Liberti, Darrell N. Kotton, Pauline M. Rudd, Andrew A. Wilson, Noel G. McElvaney	17
7	Specific Inhibition of the NLRP3 Inflammasome as an Antiinflammatory Strategy in Cystic Fibrosis 2019 ·American Journal of Respiratory and Critical Care Medicine ·Oliver J. McElvaney, Zbigniew Zasłona, (unknown), Eva M. Pålsson‐McDermott, Fiona Boland, Cedric Gunaratnam, Erich Gulbins, Luke O'neill, Emer P. Reeves, Noel G. McElvaney	75
8	The impact of alpha-1 antitrypsin augmentation therapy on neutrophil-driven respiratory disease in deficient individuals 2018 ·Journal of Inflammation Research ·Danielle M. Dunlea, (unknown), (unknown), Noel G. McElvaney, Emer P. Reeves	24
9	5 Year Expression and Neutrophil Defect Repair after Gene Therapy in Alpha-1 Antitrypsin Deficiency 2017 ·Molecular Therapy ·Christian Mueller, Gwladys Gernoux, Alisha M. Gruntman, Florie Borel, Emer P. Reeves, Roberto Calcedo, Farshid N. Rouhani, Anthony T. Yachnis, Margaret Humphries, Martha Campbell‐Thompson, Louis M. Messina, Jeffrey D. Chulay, Bruce C. Trapnell, James M. Wilson, Noel G. McElvaney, Terence R. Flotte	82
10	Animal Models of Cystic Fibrosis Pathology: Phenotypic Parallels and Divergences 2016 ·BioMed Research International ·Gillian Lavelle, Michelle M. White, Niall Browne, Noel G. McElvaney, Emer P. Reeves	77
11	The Acoustic Features of Inhalation can be Used to Quantify Aerosol Delivery from a Diskus™ Dry Powder Inhaler 2014 ·Pharmaceutical Research ·Jansen N. Seheult, P. O’Connell, (unknown), (unknown), (unknown), Imran Sulaiman, Elaine MacHale, Shona D’Arcy, Martin S. Holmes, David A. Bergin, Emer P. Reeves, Richard B. Reilly, Gloria Crispino-O’Connell, Carsten Ehrhardt, Anne Marie Healy, Richard W. Costello	42
12	Airway inflammatory markers in individuals with cystic fibrosis and non-cystic fibrosis bronchiectasis 2013 ·Journal of Inflammation Research ·Emer P. Reeves, (unknown), M. A. Hurley, (unknown), Alysia Cox, Anthony J. Ryan, Michael F. O‘Neill, Noel G. McElvaney	47
13	The role of TIM-containing molecules in airway disease and their potential as therapeutic targets 2012 ·Journal of Inflammation Research ·Emer P. Reeves, (unknown), Noel G. McElvaney	13
14	The Effect of Aspergillus fumigatus Infection on Vitamin D Receptor Expression in Cystic Fibrosis 2012 ·American Journal of Respiratory and Critical Care Medicine ·(unknown), Sanjay H. Chotirmall, J. A. A. Renwick, Tidi Hassan, Teck Boon Low, Gudmundur Bergsson, (unknown), Kathleen Bennett, Katie Dunne, Catherine M. Greene, Cedric Gunaratnam, Kevin Kavanagh, (unknown), Philip G. Murphy, Emer P. Reeves, Noel G. McElvaney	83
15	Nebulized Hypertonic Saline Decreases IL-8 in Sputum of Patients with Cystic Fibrosis 2011 ·American Journal of Respiratory and Critical Care Medicine ·Emer P. Reeves, Michael Williamson, Shane O’Neill, Peter Greally, Noel G. McElvaney	70
16	IL-8 Dictates Glycosaminoglycan Binding and Stability of IL-18 in Cystic Fibrosis 2009 ·The Journal of Immunology ·Emer P. Reeves, Michael Williamson, Barry J. Byrne, David A. Bergin, Stephen G. J. Smith, Peter Greally, Richard O’Kennedy, Shane O’Neill, Noel G. McElvaney	39
17	LL-37 Complexation with Glycosaminoglycans in Cystic Fibrosis Lungs Inhibits Antimicrobial Activity, Which Can Be Restored by Hypertonic Saline 2009 ·The Journal of Immunology ·Gudmundur Bergsson, Emer P. Reeves, Paul McNally, Sanjay H. Chotirmall, Catherine M. Greene, Peter Greally, Philip G. Murphy, Shane O’Neill, Noel G. McElvaney	110
18	Exploiting the potential of insects for in vivo pathogenicity testing of microbial pathogens 2003 ·FEMS Microbiology Reviews ·Kevin Kavanagh, Emer P. Reeves	305
19	Multiple transformation ofSaccharomyces cerevisiaeby protoplast fusion 1992 ·FEMS Microbiology Letters ·Emer P. Reeves, Kevin Kavanagh, Peter Whittaker	3
20	Multiple transformation of Saccharomyces cerevisiae by protoplast fusion 1992 ·FEMS Microbiology Letters ·Emer P. Reeves	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact